NVCR Past Earnings image   This NVCR past earnings page last updated 4/10/2024
NVCR Past Earnings
PeriodPast Earnings DateGAAP
Q4 20232/22/2024-0.450
Q3 202310/26/2023-0.460
Q2 20237/27/2023-0.540
Q1 20235/4/2023-0.500
Q4 20222/23/2023-0.360
Q3 202210/27/2022-0.250
Q2 20227/28/2022-0.230
Q1 20224/28/2022-0.040
Q4 20212/24/2022-0.250
Q3 202110/28/2021-0.130
Q2 20217/29/2021-0.140
Q1 20214/29/2021-0.040
Q4 20202/25/20210.040
Q3 202010/29/20200.090
Q2 20207/30/20200.020
Q1 20204/30/20200.040
Q4 20192/27/20200.040
Q3 201910/31/20190.020
Q2 20197/25/2019-0.010
Q1 20195/2/2019-0.130
Q4 20182/28/2019-0.17
Q3 201810/25/2018-0.13
Q2 20187/26/2018-0.17
Q1 20184/26/2018-0.23
Q4 20172/22/2018-0.12
Q3 201710/26/2017-0.13
Q2 20177/27/2017-0.24
Q1 20174/27/2017-0.21
Q4 20162/23/2017-0.26
Q3 201611/2/2016-0.39
Q2 20167/28/2016-0.48
Q1 20165/9/2016-0.42
Q4 20152/29/20162.54
Q3 201510/26/2015-2.09
NVCR Past Revenue
PeriodPast Earnings DateGAAP
Q4 20232/22/20240.13B
Q3 202310/26/20230.13B
Q2 20237/27/20230.13B
Q1 20235/4/20230.12B
Q4 20222/23/20230.13B
Q3 202210/27/20220.13B
Q2 20227/28/20220.14B
Q1 20224/28/20220.14B
Q4 20212/24/20220.13B
Q3 202110/28/20210.13B
Q2 20217/29/20210.13B
Q1 20214/29/20210.13B
Q4 20202/25/20210.14B
Q3 202010/29/20200.13B
Q2 20207/30/20200.12B
Q1 20204/30/20200.10B
Q4 20192/27/20200.10B
Q3 201910/31/20190.09B
Q2 20197/25/20190.09B
Q1 20195/2/20190.07B
Q4 20182/28/201969.67M
Q3 201810/25/201864.76M
Q2 20187/26/201861.51M
Q1 20184/26/201852.12M
Q4 20172/22/201853.66M
Q3 201710/26/201750.11M
Q2 20177/27/201738.38M
Q1 20174/27/201734.88M
Q4 20162/23/201730.24M
Q3 201611/2/201621.67M
Q2 20167/28/201617.92M
Q1 20165/9/201613.05M
Q4 20152/29/201612.38M
Q3 201510/26/20158.95M
Quotes delayed 20 minutes

Email EnvelopeFree NVCR Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
NovoCure (NVCR) is categorized under the Miscellaneous sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

NVTS Past Earnings
OCDX Past Earnings
OCEA Past Earnings
ORGN Past Earnings
OWLT Past Earnings
OXBR Past Earnings
PEAR Past Earnings
PET Past Earnings
PROK Past Earnings
PRSO Past Earnings

NVCR Past Earnings Q&A

What was the best and worst NVCR past earnings results?
For NovoCure, I'm wondering what the company's very best and worst earnings results have been, on an earnings per share basis?

✔️Accepted answer: The highest NVCR past earnings result in our data set was 2.54/share posted in Q4 2015, while the lowest was in Q3 2015 when NVCR posted -2.09/share.

  Suggested answer: The biggest top line earnings performance — aka revenue — quarter was in Q4 2020 when NVCR reported 0.14B in revenue, while the quarter with the lowest revenue in our data set was Q3 2015 at 8.95M of revenue.

  Suggested answer: There are 34 NVCR past earnings results in our data set.

On this page we presented the NVCR past earnings date information for NovoCure. Reviewing that NVCR Past Earnings for the company, we see that the highest past earnings result in our data set was in Q4 2015, when NVCR posted gaap of 2.54/share. Meanwhile the lowest NVCR past earnings result was in Q3 2015, when NVCR posted gaap of -2.09/share. Turning to top line revenue performance, the biggest revenue quarter in our data set was seen in Q4 2020 when NVCR reported 0.14B in revenue, while the smallest revenue quarter was Q3 2015 when NVCR reported 8.95M in revenue.

Any self directed investor doing their due diligence on NVCR or any other given stock can benefit from researching all of the NovoCure past earnings — and here, we present each quarter's result all together on one page for easy comparison. Studying this information can help when projecting future earnings, as well as determining whether the past earnings trajectory justifies the current stock value. That's why we bring you PastEarnings.com to make it easy for investors to investigate NovoCure past earnings, or the past earnings information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for NVCR. Thanks for visiting, and the next time you need to research NVCR past earnings or those of another stock, we hope you'll think of our site, as your go-to past earnings research resource of choice.

Recommended: ETFs Holding QTS, Institutional Holders of KCE, AMED Videos.


NVCR Past Earnings | www.PastEarnings.com | Copyright © 2020 - 2024, All Rights Reserved

Nothing in PastEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
Wait! Don't leave yet.
Want to receive our latest research absolutely free?

Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.